一种动态的共同表达方法揭示了Gins2作为HNSCC转移的潜在上游调节器
Nasibeh Khayer1, Samira Shabani2, Maryam Jalessi1,3
1Skull Base Research Center, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Scientific reports
|January 26, 2025
概括
这项研究揭示了关键的分子相互作用驱动头部和部状细胞癌 (HNSCC) 转移. 它确定PI3K/AKT/mTOR通路和特定的基因,如Gins2,对于癌症传播和患者预后至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 头部和部状细胞癌 (HNSCC) 是具有高转移风险和有限的治疗选择,导致显著的死亡率的侵袭性.
- 在HNSCC中,远程转移与预后不佳有关,但其分子驱动因素尚不清楚.
- 传统的共同表达方法无法捕捉复杂的,动态的分子相互作用,这对癌症进展至关重要.
研究的目的:
- 通过一种新的三向相互作用方法,研究HNSCC转移背后的动态分子机制.
- 确定生物相关的基因相互作用和涉及HNSCC进展的途径.
- 评估HNSCC.中确定的分子参与者的预后意义.
主要方法:
- 采用一种新的三向相互作用方法来分析HNSCC中的动态基因共同表达.
- 利用基因组丰富分析和基因调控网络重建来识别重要的生物途径.
- 在蛋白质水平上验证已识别的基因三重体,以确认生物相关性.
主要成果:
- PI3K/AKT/mTOR (PAM) 信号通路被确定为HNSCC转移中的关键中断通路.
- 发现了一种涉及开关基因Gins2和基因对{Akt2,Anxa2}的显著三重组,涉及Gins2在HNSCC转移中.
- 生存分析强调C19orf33和Usp13作为HNSCC的潜在预后生物标志物.
结论:
- Gins2可能会在PAM信号通路中充当上游调节器,这对HNSCC远程转移至关重要.
- 鉴定的基因相互作用为HNSCC分子病理学提供了新的见解.
- C19orf33和Usp13显示出作为预后标记物的潜力,有助于HNSCC患者的管理.
相关概念视频
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...


